Zobrazeno 1 - 3
of 3
pro vyhledávání: '"C E, de Keyser"'
Autor:
Xiaohui Li, James D. Stewart, Rikje Ruiter, Yongmei Liu, Joop Jukema, Donna K. Arnett, Leslie A. Lange, Daniel S. Evans, Jerome I. Rotter, Solomon K. Musani, Susan R. Heckbert, Christy L. Avery, L. de las Fuentes, D. C. Rao, C E de Keyser, Steve Cummings, L. A. Cupples, Kerri L. Wiggins, Y-Di Chen, David J. Stott, Vilmundur Gudnason, Ulrich Broeckel, Yun J. Sung, T.B. Harris, B. H. Stricker, J. C. Bis, M. A. Ikram, Kent D. Taylor, Traci M. Bartz, Fangui Sun, Nona Sotoodehnia, Nicholas L. Smith, Colleen M. Sitlani, L. J. Launer, Eric A. Whitsel, Alexander P. Reiner, A.G. Uitterlinden, Karen Schwander, Xuejiang Guo, Adolfo Correa, Hanfei Xu, Albert V. Smith, Til Stürmer, James S. Floyd, James G. Wilson, Ramachandran S. Vasan, Evan L. Busch, Bruce M. Psaty, Stella Trompet, Ian Ford
Publikováno v:
Pharmacogenomics Journal, 20(3), 482-493. Nature Publishing Group
The pharmacogenomics journal
The pharmacogenomics journal, vol 20, iss 3
Pharmacogenomics Journal, 20(3), 482-493. NATURE PUBLISHING GROUP
The pharmacogenomics journal
The pharmacogenomics journal, vol 20, iss 3
Pharmacogenomics Journal, 20(3), 482-493. NATURE PUBLISHING GROUP
Hypertension (HTN) is a significant risk factor for cardiovascular morbidity and mortality. Metabolic abnormalities, including adverse cholesterol and triglycerides (TG) profiles, are frequent comorbid findings with HTN and contribute to cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f149bd21077f1f4f66b609ac099934ee
https://pure.eur.nl/en/publications/2ec9a20e-6a5b-43c6-8d93-6dda47f39ab5
https://pure.eur.nl/en/publications/2ec9a20e-6a5b-43c6-8d93-6dda47f39ab5
Autor:
T, Dujic, K, Zhou, S W, Yee, N, van Leeuwen, C E, de Keyser, M, Javorský, S, Goswami, L, Zaharenko, M M, Hougaard Christensen, M, Out, R, Tavendale, M, Kubo, M M, Hedderson, A A, van der Heijden, L, Klimčáková, V, Pirags, A, Kooy, K, Brøsen, J, Klovins, S, Semiz, I, Tkáč, B H, Stricker, Cna, Palmer, L M, 't Hart, K M, Giacomini, E R, Pearson
Publikováno v:
Dujic, T, Zhou, K, Yee, S W, van Leeuwen, N, de Keyser, C E, Javorský, M, Goswami, S, Zaharenko, L, Hougaard Christensen, M M, Out, M, Tavendale, R, Kubo, M, Hedderson, M M, van der Heijden, A A, Klimčáková, L, Pirags, V, Kooy, A, Brøsen, K, Klovins, J, Semiz, S, Tkáč, I, Stricker, B H, Palmer, C N A, 't Hart, L M, Giacomini, K M & Pearson, E R 2017, ' Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin : A Metgen Meta-Analysis ', Clinical Pharmacology and Therapeutics, vol. 101, no. 6, pp. 763-772 . https://doi.org/10.1002/cpt.567
Clinical Pharmacology and Therapeutics, 101(6), 763-772
Dujic, T, Zhou, K, Yee, S W, van Leeuwen, N, de Keyser, C E, Javorský, M, Goswami, S, Zaharenko, L, Christensen, M M H, Out, M, Tavendale, R, Kubo, M, Hedderson, M M, van der Heijden, A A, Klimčáková, L, Pirags, V, Kooy, A, Brøsen, K, Klovins, J, Semiz, S, Tkáč, I, Stricker, B H, Palmer, C N A, 't Hart, L M, Giacomini, K M & Pearson, E R 2017, ' Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin : A MetGen Meta-Analysis ', Clinical Pharmacology & Therapeutics, vol. 101, no. 6, pp. 763-772 . https://doi.org/10.1002/cpt.567
Clinical pharmacology and therapeutics, vol 101, iss 6
Clinical Pharmacology & Therapeutics, 101(6), 763-772. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 101(6), 763-772. Wiley-Blackwell
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 101(6), 763-772
Dujic, T, Zhou, K, Yee, S W, van Leeuwen, N, de Keyser, C E, Javorský, M, Goswami, S, Zaharenko, L, Christensen, M M H, Out, M, Tavendale, R, Kubo, M, Hedderson, M M, van der Heijden, A A, Klimčáková, L, Pirags, V, Kooy, A, Brøsen, K, Klovins, J, Semiz, S, Tkáč, I, Stricker, B H, Palmer, C N A, 't Hart, L M, Giacomini, K M & Pearson, E R 2017, ' Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin : A MetGen Meta-Analysis ', Clinical Pharmacology & Therapeutics, vol. 101, no. 6, pp. 763-772 . https://doi.org/10.1002/cpt.567
Clinical pharmacology and therapeutics, vol 101, iss 6
Clinical Pharmacology & Therapeutics, 101(6), 763-772. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 101(6), 763-772. Wiley-Blackwell
Clinical Pharmacology and Therapeutics
Therapeutic response to metformin, a first-line drug for type 2 diabetes (T2D), is highly variable, in part likely due to genetic factors. To date, metformin pharmacogenetic studies have mainly focused on the impact of variants in metformin transport
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b762e525da754cb923dd8b91cd06ac1f
https://research.vumc.nl/en/publications/508fedaf-498a-4e2d-91a9-f7fedd97684b
https://research.vumc.nl/en/publications/508fedaf-498a-4e2d-91a9-f7fedd97684b
Autor:
A-H Maitland-van der Zee, A. Hofman, Mark Eijgelsheim, Eric J.G. Sijbrands, J. C. M. Witteman, B.H.Ch. Stricker, C E de Keyser, C M van Duijn, A.G. Uitterlinden
Publikováno v:
Pharmacogenomics Journal, 11(1), 72-80. Nature Publishing Group
The objective of this study was to investigate whether common variation in genes involved in lipid metabolism modify the effect of statins on serum total cholesterol concentration. Statin users were identified in the Rotterdam Study, a prospective po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df50c0bf9e2b0c21dc177914765d8ad5
https://pure.eur.nl/en/publications/2028beae-03f6-49d7-b96e-d071fc20a29c
https://pure.eur.nl/en/publications/2028beae-03f6-49d7-b96e-d071fc20a29c